Abstract:Acquired resistance is one of the major causes of failure of standard therapies in cancer patients. Chemotherapeutic agents are still widely used and the understanding of the mechanisms leading to secondary resistance to these molecules are still puzzling. Recently, the role of the tumor immune microenvironment has been recognized. Among the cells potentially involved, macrophages seem to be the perfect culprits. In a previous work, we have shown that hypoxic macrophages are able to provide strong protection against 5-fluorouracil, a first-line chemotherapeutic agent in digestive cancers. In the present work, we use mathematical modeling to explore the spatiotemporal aspects of the treatment-induced organization of the tumor environment. Based on analytical and numerical analysis, we propose that macrophage-driven protection against chemotherapy under treatment does not rely solely on biochemical degradation, but is enhanced by the emergence of spatially structured chemotherapeutic protective niches. This work paves the way for the development of new therapeutic strategies that rely on targeting the spatial organization of tumors as a way to control treatment resistance.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is the mechanism of tumor resistance to chemotherapeutic drugs, especially the role of macrophages in it. Specifically, the research focuses on how tumor - associated macrophages (TAMs) promote tumor resistance to chemotherapeutic drugs (such as 5 - fluorouracil, 5 - FU) by forming chemoprotective niches. Through the method of mathematical modeling, the paper explores the changes in spatial organization in the tumor microenvironment under chemotherapy induction, especially the formation mechanism of macrophage - driven chemoprotective niches. ### Main Problem Analysis 1. **Mechanism of Chemotherapy Resistance** - Chemotherapy resistance is a major problem in cancer treatment, especially in digestive system cancers. 5 - fluorouracil (5 - FU) is a commonly used chemotherapeutic drug. - Macrophages express dihydropyrimidine dehydrogenase (DPD) in a hypoxic environment. This enzyme can metabolize 5 - FU into inactive products, thus protecting tumor cells from the effects of chemotherapy. 2. **Formation of Spatial Organization** - The paper analyzes the changes in the spatial distribution of macrophages and cancer cells in the tumor microenvironment under chemotherapy induction through mathematical modeling. - The model takes into account factors such as macrophage chemotaxis, cancer cell proliferation, and chemotherapy drug diffusion, revealing how macrophages enhance tumor resistance by forming spatially structured chemoprotective niches. 3. **Effect of Chemotherapy Dose** - The study found that the chemotherapy dose can effectively drive the formation of spatial organization only within a certain range. When the dose is too low, macrophages will rapidly degrade the chemotherapy drug; when the dose is too high, the degradation ability of macrophages will be overwhelmed. - Through numerical simulation, the study determined the effective range of chemotherapy dose and verified that chemotherapy within this range can induce the formation of spatial organization. ### Mathematical Model The paper uses a continuous model and an agent - based model (ABM) to study the above problems. The following are the main equations of the model: #### Continuous Model \[ \begin{cases} \frac{\partial m}{\partial t}=d\nabla^{2}m - \chi\nabla\cdot(m\nabla a)\\ \frac{\partial k}{\partial t}=d\nabla^{2}k+\alpha k\left(1 - \frac{k}{K}\right)-\beta k c\\ \frac{\partial c}{\partial t}=D\nabla^{2}c + s-\gamma m c\\ \frac{\partial a}{\partial t}=D\nabla^{2}a+\delta k-\eta a \end{cases} \] - \(m(x,t)\): macrophage density - \(k(x,t)\): cancer cell density - \(c(x,t)\): chemotherapy drug concentration - \(a(x,t)\): chemokine concentration - \(d\): diffusion coefficient - \(\chi\): chemotactic coefficient - \(\alpha\): cancer cell growth rate - \(K\): environmental capacity - \(\beta\): mortality rate caused by chemotherapy drugs - \(\gamma\): rate of macrophage - mediated chemotherapy drug degradation - \(s\): chemotherapy drug source term - \(\delta\): rate of chemokine secretion by cancer cells - \(\eta\): spontaneous degradation rate of chemokines #### Based - agent Model - Using the PhysiCell simulator, it takes into account the behavior and interactions of individual cells. - It simulates the initial random distribution of cancer cells, chemokine secretion, uniform distribution of chemotherapy drugs, and macrophage chemotaxis. - Through numerical simulation, it is verified that the protective niches formed by macrophages under the guidance of chemokines can significantly increase the survival rate of cancer cells. ### Conclusion Through mathematical modeling and numerical simulation, the paper reveals the important contribution of chemoprotective niches formed by macrophages under chemotherapy induction to tumor resistance.

Spatial organization of mediated-macrophage chemoprotective niches in solid tumors: A mathematical analysis

Mathematical modeling of tumor-associated macrophage interactions with the cancer microenvironment

Emergence of Anti-Cancer Drug Resistance: Exploring the Importance of the Microenvironmental Niche via a Spatial Model

Mathematical Modeling Predicts Synergistic Antitumor Effects of Combining a Macrophage-Based, Hypoxia-Targeted Gene Therapy with Chemotherapy

Spatial Metrics of Interaction between CD163-Positive Macrophages and Cancer Cells and Progression-Free Survival in Chemo-Treated Breast Cancer

Mathematical investigation into the role of macrophage heterogeneity on the temporal and spatio-temporal dynamics of non-small cell lung cancers

Abstract 4916: Spatial analysis of local drug induced changes in tumor microenvironment predicts effective treatment combinations in breast cancer

Limiting the development of anti-cancer drug resistance in a spatial model of micrometastases

Abstract A122: Deciphering macrophage targeting cancer immunotherapies using a novel in vitro assay modelling the tumor microenvironment

Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment

Mathematical Modeling of the Metastatic Colorectal Cancer Microenvironment Defines the Importance of Cytotoxic Lymphocyte Infiltration and Presence of PD-L1 on Antigen Presenting Cells

Effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors

Spatial structure impacts adaptive therapy by shaping intra-tumoral competition

Abstract SY37-03: Leveraging the complexities of tumor associated macrophages for effective anti-cancer therapy

Computational simulations of tumor growth and treatment response: Benefits of high-frequency, low-dose drug regimens and concurrent vascular normalization

Nutrient sensing in macrophages linked to reorganized tumor vasculature

Abstract 5493: Mathematical modeling of antibody nanoconjugates transport quantifies the impact of the tumor microenvironment on drug penetration

Mathematical Modeling Reveals That the Administration of EGF Can Promote the Elimination of Lymph Node Metastases by PD-1/PD-L1 Blockade

Computational Modeling of 3D Tumor Growth and Angiogenesis for Chemotherapy Evaluation

Multi-scale modeling of macrophage—T cell interactions within the tumor microenvironment

Investigation of cancer response to chemotherapy: a hybrid multi-scale mathematical and computational model of the tumor microenvironment